CONFERENCE ON AIDS PATHOGENESIS

艾滋病发病机制会议

基本信息

  • 批准号:
    2724652
  • 负责人:
  • 金额:
    $ 2.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-01-01 至 1999-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from the application) AIDS has captured the attention of the biomedical community for almost two decades. It continues to be a major health problem worldwide, especially in developing countries. In the last few years, there has been exciting progress both at the clinical front and in our basic understanding of HIV pathogenesis. With the advent of combination therapy and potent antiviral drugs, HIV infection is no longer a death sentence. However, recent data suggest that virus eradication is probably impossible once a person is infected, thus making therapy a lifelong requirement. There is already panic over the lack of alternatives once the current 3 or 4 drug regimens fail. New insights into the mechanisms of HIV replication and pathogenesis should lead to the identification of new therapeutic targets and treatment options. This is well illustrated in the recent discovery of the role of chemokine receptors in virus entry, which has provided stimulus to both academic and industrial scientists to pursue new strategies for virus inhibition. The goal of this meeting is to provide a forum for scientists to review state-of-the-art knowledge on HIV gene structure and function, virus-host interactions, pathogenic mechanisms, and issues related to therapy for HIV infection. It is hoped that the information exchange, discussion and cross fertilization will spark new ideas, collaborations and approaches to battle this viral disease.
描述:(改编自应用程序)艾滋病已经捕获了

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Flossie Wong-Staal其他文献

Flossie Wong-Staal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Flossie Wong-Staal', 18)}}的其他基金

Investigation of the Potential Anti-Diabetic Activity of ITX2158 In Vivo
ITX2158 体内潜在抗糖尿病活性的研究
  • 批准号:
    7608527
  • 财政年份:
    2009
  • 资助金额:
    $ 2.8万
  • 项目类别:
Development of HIV vectors for antiviral and immune based therapies
开发用于抗病毒和免疫疗法的 HIV 载体
  • 批准号:
    6642250
  • 财政年份:
    2002
  • 资助金额:
    $ 2.8万
  • 项目类别:
Development of HIV vectors for antiviral and immune based therapies
开发用于抗病毒和免疫疗法的 HIV 载体
  • 批准号:
    6484680
  • 财政年份:
    2001
  • 资助金额:
    $ 2.8万
  • 项目类别:
Development of HIV vectors for antiviral and immune based therapies
开发用于抗病毒和免疫疗法的 HIV 载体
  • 批准号:
    6336287
  • 财政年份:
    2000
  • 资助金额:
    $ 2.8万
  • 项目类别:
Development of HIV vectors for antiviral and immune based therapies
开发用于抗病毒和免疫疗法的 HIV 载体
  • 批准号:
    6224439
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:
Development of HIV vectors for antiviral and immune based therapies
开发用于抗病毒和免疫疗法的 HIV 载体
  • 批准号:
    6314013
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
用于 HIV 基因治疗的慢病毒载体
  • 批准号:
    6312137
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
用于 HIV 基因治疗的慢病毒载体
  • 批准号:
    6374258
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
用于 HIV 基因治疗的慢病毒载体
  • 批准号:
    6170615
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
用于 HIV 基因治疗的慢病毒载体
  • 批准号:
    2909181
  • 财政年份:
    1999
  • 资助金额:
    $ 2.8万
  • 项目类别:

相似海外基金

Accelerated Lung Aging in People Living with Human Immunodeficiency Virus
人类免疫缺陷病毒感染者的肺部老化加速
  • 批准号:
    488843
  • 财政年份:
    2023
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Operating Grants
Health inequalities among people diagnosed with human immunodeficiency virus and tuberculosis in Manitoba: Missed opportunities in the access to testing, treatment, and linkage to care
马尼托巴省被诊断患有人类免疫缺陷病毒和结核病的人之间的健康不平等:错过了获得检测、治疗和护理联系的机会
  • 批准号:
    495202
  • 财政年份:
    2023
  • 资助金额:
    $ 2.8万
  • 项目类别:
Accelerated Lung Aging in People Living with Human Immunodeficiency Virus
人类免疫缺陷病毒感染者的肺部老化加速
  • 批准号:
    483581
  • 财政年份:
    2023
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Operating Grants
Investigating the Role of Aging Biomarkers in Human Immunodeficiency Virus (HIV) Neurocognitive Disorders
研究衰老生物标志物在人类免疫缺陷病毒 (HIV) 神经认知障碍中的作用
  • 批准号:
    486500
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Studentship Programs
Characterizing Surface Proteins on Human Immunodeficiency Virus Particles
人类免疫缺陷病毒颗粒表面蛋白的表征
  • 批准号:
    559260-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Design and Development of a Chatbot-based Personalized Healthcare Tool to Support People with Human Immunodeficiency Virus (HIV)
设计和开发基于聊天机器人的个性化医疗工具,为人类免疫缺陷病毒 (HIV) 患者提供支持
  • 批准号:
    569305-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Utilizing optical coherence tomography and exercise to develop novel biomarkers of respiratory impairment in people living with human immunodeficiency virus
利用光学相干断层扫描和运动来开发人类免疫缺陷病毒感染者呼吸损伤的新型生物标志物
  • 批准号:
    477100
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Salary Programs
Perspectives on continuing care, from home care to long-term care, for aging persons with Human Immunodeficiency Virus: through the lens of those with lived experience
对患有人类免疫缺陷病毒的老年人的持续护理(从家庭护理到长期护理)的看法:通过生活经验者的视角
  • 批准号:
    467747
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Operating Grants
Effect of Physical Maturation and Sexual Debut on Human Immunodeficiency Virus Susceptibility in Adolescent Males
青春期男性身体成熟和性行为对人类免疫缺陷病毒易感性的影响
  • 批准号:
    486558
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
    Studentship Programs
Evaluation of triage strategies and screening intervals in a human papillomavirus based cervical cancer screening program in women living with human immunodeficiency virus in Botswana
博茨瓦纳人类免疫缺陷病毒感染妇女基于人乳头瘤病毒的宫颈癌筛查计划的分诊策略和筛查间隔的评估
  • 批准号:
    10483598
  • 财政年份:
    2022
  • 资助金额:
    $ 2.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了